Search

everythinglearnresearchcommunity

for

Search:↓

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Newly made nicotinamide compounds could potentially treat cancer.

Tofacitinib taken by mouth helps treat hair loss in children.

MVP treatment is effective and safe for recurrent breast cancer.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Certain drugs that block specific enzymes can help treat prostate diseases.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

A man had bad reactions to a hair loss treatment called DNCB.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

JAK inhibitors show promise in treating difficult skin diseases.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.